Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05171179 · ClinicalTrials.gov registry record · Phase 3
The Use of Pecs Blocks in Combination With Exparel in Breast Reconstruction Surgery
A Phase 3 study, sponsored by Northwestern University.
- Completed
- Registry status
- Phase 3
- Development phase
- 60
- Enrollment target
NCT05171179: Completed Phase 3 study, sponsored by Northwestern University.
NCT05171179 is a Phase 3 study that has completed, run by Northwestern University. The registered enrollment target is 60 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05171179, a Phase 3 study, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 60 participants
- Enrollment target
Study Summary
This project intends to more thoroughly investigate the direct influence of Pecs blocks in the administration of Exparel, a non-opioid analgesic, in breast reconstruction surgery. The hypothesis is that this analgesic delivery method will significantly reduce negative outcomes such as post-operative pain, opioid use, and nausea while increasing positive outcomes such as post-operative physical activity.
Primary Outcome
• Investigate amount of post-operative opioid consumption post operatively
Interventions
- DRUG Bupivacaine
- DRUG Exparel
- PROCEDURE Breast Reconstruction (Mammaplasty)
- DEVICE Pecs blocks
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2021-10-22 |
| Est. Completion | 2025-07-01 |
| Phase | Phase 3 |
What the finished NCT05171179 record still lists
NCT05171179 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (92% lower).
The record links to 0 conditions, and to 4 interventions - of which Bupivacaine is the first listed.
NCT05171179 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05171179 about?
NCT05171179 is a clinical study titled "The Use of Pecs Blocks in Combination With Exparel in Breast Reconstruction Surgery". This project intends to more thoroughly investigate the direct influence of Pecs blocks in the administration of Exparel, a non-opioid analgesic, in breast reconstruction surgery. The hypothesis is that this analgesic delivery method will significantly reduce negative outcomes such as post-operative...
What is the current status of trial NCT05171179?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 60 participants. The study started on 2021-10-22. Estimated completion is 2025-07-01.
What interventions are being tested in trial NCT05171179?
The interventions under investigation include: Bupivacaine (DRUG), Exparel (DRUG), Breast Reconstruction (Mammaplasty) (PROCEDURE), Pecs blocks (DEVICE).
Who is sponsoring clinical trial NCT05171179?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05171179's enrollment target sits among peer trials
60 1804th of 2000 higher than 177 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI